SEATTLE, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Intrinsic Medicine, Inc. (Intrinsic), a therapeutics company leveraging human milk biology to transform Gut-Brain Axis...
Professor Dr. med. Matthias Dobbelstein Professor Dr. med. Matthias DobbelsteinJerusalem, Dec. 06, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals...
The Baranzate site (Italy) is the first Dipharma manufacturing facility to receive Anvisa certificationMILAN, Italy, Dec. 01, 2022 (GLOBE NEWSWIRE)...
Initial CD388 clinical data expected in the first half of 2023SAN DIEGO, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Cidara Therapeutics,...
60% Confirmed Disease Control Rate1 and 7.4 Months Median Time to Tumor Progression for Ewing Sarcoma First-Relapse Patients No Disease...
SOLANA BEACH, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily...
CTIM-76 named as lead candidate to target Claudin 6 positive cancers IND submission expected in Q1 2024 Context to host...
Regulatory clearance lays key technological and regulatory foundation for BT BeaMedical’s vision of revolutionizing treatment options in neurosurgery, oncology, and...
SAN FRANCISCO, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient...
Lexington Facility uniQure's commercial manufacturing facility in Lexington, MA Manufacturing State-of-the-art global commercial manufacturing at uniQure~ Historic approval provides a...
Chooses Automated Pre-Bill Coding Analysis to Improve Financial Performance Atlanta, GA, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Streamline Health Solutions,...
BOCA RATON, Fla., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Released at the CNS Summit in Boca Raton, FL, the CNS...
The gift will create the Antimicrobial Resistance Discovery Incubator, which will fund innovative new projects to prevent and treat drug...
Three Months Ended September 30, 2022 (2021)Nine Months Ended September 30, 2022 (2021)Revenue was SEK 2.4 M (2.3 M)Revenue...
Following success of Hizentra App, CSL Behring and BrightInsight expand partnership to build apps for rare disease medicines across the...
This forecast is based on estimates generated through a recent pilot program and scaled through approximately 250,000 independent primary care...
BOSTON, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Yumanity Therapeutics, Inc. (“Yumanity” or the “Company”) (Nasdaq: YMTX), a clinical-stage biopharmaceutical company,...
Company announcement No. 51 / 2022 Zealand Pharma Announces Financial Results for the First Nine Months of 2022 Copenhagen, Denmark...
MISSISSAUGA, Ontario, Nov. 10, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its...
HOUSTON, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and...